<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="0" ids="34306">20-Hydroxyeicosatetraenoic acid</z:chebi> is a potent vasoconstrictor that contributes to <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>An inhibitor of <z:chebi fb="0" ids="34306">20-Hydroxyeicosatetraenoic acid</z:chebi> synthesis, TS-011, reduces <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and improves neurological deficits in animal <z:hpo ids='HP_0001297'>stroke</z:hpo> models </plain></SENT>
<SENT sid="2" pm="."><plain>However, little is known about how TS-011 affects the microvessels in ischaemic brain </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we investigated the effect of TS-011 on microvessels after <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>EXPERIMENTAL APPROACH: TS-011 (0.3 mgÂ·kg(-1) ) or a vehicle was infused intravenously for 1 h every 6 h in a mouse model of <z:hpo ids='HP_0001297'>stroke</z:hpo>, induced by transient occlusion of the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> following photothrombosis </plain></SENT>
<SENT sid="5" pm="."><plain>The cerebral blood flow velocity and the vascular perfusion area of the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> microvessels were measured using in vivo two-<z:chebi fb="23" ids="30212">photon</z:chebi> imaging </plain></SENT>
<SENT sid="6" pm="."><plain>KEY RESULTS: The cerebral blood flow velocities in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> microvessels decreased at 1 and 7 h after reperfusion, followed by an increase at 24 h after reperfusion in the vehicle-treated mice </plain></SENT>
<SENT sid="7" pm="."><plain>We found that TS-011 significantly inhibited both the decrease and the increase in the blood flow velocities in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> microvessels seen in the vehicle-treated mice after reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, TS-011 significantly inhibited the reduction in the microvascular perfusion area after reperfusion, compared with the vehicle-treated group </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, TS-011 significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 40% at 72 h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS AND IMPLICATIONS: These findings demonstrated that infusion of TS-011 improved defects in the autoregulation of peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> microcirculation and reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="11" pm="."><plain>Our results could be relevant to the treatment of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
</text></document>